Ofatumumab. (Q34116104)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Ofatumumab.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Ofatumumab. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Mark Sanford

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Paul L McCormack

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1013-1019

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

1 reference

https://api.crossref.org/works/10.2165%2F11203850-000000000-00000

21 January 2018

Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis

1 reference

https://api.crossref.org/works/10.2165%2F11203850-000000000-00000

21 January 2018

Current approach to diagnosis and management of chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukaemia: a short overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of fludarabine-refractory chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11203850-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34116104&oldid=2196270986"